StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > And down we go again. Tripp the dummy.

<< Previous

Bullboard Posts

Next >>

Comment by cactuseskimoon Feb 03, 2021 10:47am

130 Views

Post# 32457890

RE:And down we go again. Tripp the dummy.

This comment will not age well me thinks.

Stockish12 wrote: Aristotle release in Q1 and we are almost into the 2nd half of Q1. And the price is still struggling to stay above $1 for a billion dollar product. LMFAO. what a joke of a company.

Billion dollar on paper, trash in the markets.

Tripp is a fool. The simplest thing a CEO with a little brain will even do is take advantage of the bullish state of the stock - when was the last time there was a PR? Yet, people have to go to other company pages/blogs/websites to see oh stagezero is doing this or that. The clowns cannot even put good news out themselves to save their own lives. Oh, ther must have a strict NR budget I am guessing. lol